See the whole embryo.
Ortabio is building multimodal decision support for IVF — bringing together preimplantation genetics, embryo imaging, and real clinical outcomes from Asian populations that current models underrepresent.
Choosing an embryo is still mostly a judgment call.
Embryologists rank embryos largely by eye. Image-only AI has struggled to reliably beat that judgment, and the genomic references behind these tools were built on populations that look little like the patients seen across Vietnam and Asia.
Morphology grading varies between embryologists and between clinics.
Most tools read one signal. The genetic ground truth stays in a separate report.
Reference datasets underrepresent Asian populations — the patients we serve.
Three signals, one decision.
Ortabio brings together the signals a clinic already produces during a cycle and learns from what actually happened next — so the model reflects real reproductive outcomes, not proxies.
Genetics
Preimplantation genetic testing (PGT-A) gives a ploidy ground truth that image-only models never see.
Imaging
Embryo morphology and morphokinetics, read consistently and at scale, without changing lab workflow.
Outcomes
Linked clinical outcomes — implantation through live birth — turn data into a signal that means something.
An adjunctive score, in the embryologist's hands.
Ortabio is designed to support the people making the call — surfacing a transparent, ranked view across all three signals. It informs the decision; it never removes the clinician from it.
Decision support, made transparent.
A preview of how Ortabio surfaces its reasoning — ranking each embryo across genetics, imaging and outcomes, and showing why, so the embryologist stays in control.
Illustrative interface — for demonstration only.
Evidence first. Claims last.
Reproductive medicine has seen enough overclaiming. We hold ourselves to the standard our clinical partners expect, and we say only what the data supports.
Reported to TRIPOD+AI
Model development and validation follow recognised prediction-model reporting standards.
Patient-level, multicentre validation
Data is split by patient to avoid leakage, with external validation across clinics planned before any clinical claim.
An aid, not a replacement
Built as adjunctive decision support. The embryologist stays responsible for every transfer decision.
Privacy by design
Clinical data is de-identified at source and governed by defined data-transfer agreements.
Clinical & data foundation
Built with Genome.
Our platform is grounded in the clinical depth of Genome — operating since 2017 and CAP-accredited across preimplantation testing (PGT), prenatal screening (NIPT) and solid-tumour NGS, with external quality assurance from GenQA and EMQN. Genome is the source of the linked, high-quality reproductive data that makes Ortabio possible.
Visit genome.com.vn →Clinicians and builders, together.
Nam Nguyen
Ex-Salesforce · Ex-Oracle. Founder of Ortabio, leading strategy, product and fundraising toward a multimodal embryo-selection platform for IVF.
LinkedIn
Assoc. Prof. Quan Thanh Tho
Associate Professor and Dean of Computer Science & Engineering at HCMUT; PhD from NTU Singapore. Researches AI, natural language processing, intelligent systems and formal methods.
Faculty profile
Assoc. Prof. Dang Tien Truong
Associate Professor (MD, PhD). Head of Anatomy at the Vietnam Military Medical University and a founding scientific advisor to Genome. Specialist in preimplantation genetic testing (PGT-A/PGT-M).
Genome profileBuilding the future of embryo selection in Asia.
We're speaking with IVF clinics interested in becoming design and validation partners, and with investors who understand reproductive health and clinical AI.